secwatch / observer

8-K filed March 12, 2026, 7:59 PM ET ticker ALLO CIK 0001737287

earnings confidence high sentiment neutral materiality 0.60

Allogene Q4 net loss $38.8M; cash runway into Q1 2028; cema-cel ALPHA3 interim April 2026

Allogene Therapeutics, Inc.

Q4 net loss $38.8M ($0.17/share); FY 2025 net loss $190.9M ($0.87/share).
Cash, equivalents, investments $258.3M; runway extended into Q1 2028 via disciplined spending, $23.7M escrow return.
Pivotal Phase 2 ALPHA3 trial of cema-cel in 1L LBCL; interim futility analysis (MRD clearance, safety) planned April 2026.
Phase 1 RESOLUTION trial of ALLO-329 (CD19/CD70 CAR T) in autoimmune diseases; proof-of-concept data expected June 2026.
ALLO-316 TRAVERSE trial in RCC completed Phase 1b enrollment; exploring partnering opportunities.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-26-017230
form_type: 8-K
ticker: ALLO
cik: 0001737287
company_name: Allogene Therapeutics, Inc.
filed_at: 2026-03-12T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.035093+00:00
generated_at: 2026-05-15T13:41:10.257113+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-26-017230
json_url: https://secwatch.observer/filing/0001628280-26-017230.json
markdown_url: https://secwatch.observer/filing/0001628280-26-017230.md
text_url: https://secwatch.observer/filing/0001628280-26-017230.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1737287/000162828026017230/0001628280-26-017230-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1737287/000162828026017230/allo-20260312.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DAVEY TREE EXPERT CO

Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M

DAVEY TREE EXPERT CO June 1, 2026, 1:50 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BKE

Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M

BUCKLE INC May 29, 2026, 3:38 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

HIND

Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis

Vyome Holdings, Inc May 29, 2026, 8:42 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

PKE

Park Aerospace Q4 sales up 43% to $24.2M; EPS $0.19 vs $0.06 YoY; full-year net earnings double to $11.3M

PARK AEROSPACE CORP May 28, 2026, 4:29 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

GAP

Gap Inc. Q1 net sales up 1% to $3.5B; adj. EPS $0.38; raises full-year EPS outlook

GAP INC May 28, 2026, 4:16 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

PagerDuty Q1 revenue $121M up 1% YoY; new CEO DiLullo; $100M buyback

PagerDuty, Inc. May 28, 2026, 4:07 PM ET earnings Items 2.02, 8.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

RICK

RCI Hospitality posts Q2 GAAP loss of $0.04 on $7.6M impairment; non-GAAP EPS rises to $0.78

RCI HOSPITALITY HOLDINGS, INC. May 28, 2026, 4:07 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

NTAP

NetApp reports Q4/FY2026 results (details not in filing) and adds $1B buyback

NetApp, Inc. May 28, 2026, 4:05 PM ET earnings Items 2.02, 8.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001628280-26-017230

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.